MedPath

Continuous circadian intracerebroventricular ...

Continuous i.c.v. A-dopamine treatment for PD significantly reduces L-dopa-related complications, showing high safety and efficacy. It allows oral treatment reduction by 40-70%, decreases dyskinesias by 80%, and nearly eliminates severe "off" periods. Patients prefer long-term use with home refills.


Reference News

Continuous circadian intracerebroventricular ...

Continuous i.c.v. A-dopamine treatment for PD significantly reduces L-dopa-related complications, showing high safety and efficacy. It allows oral treatment reduction by 40-70%, decreases dyskinesias by 80%, and nearly eliminates severe "off" periods. Patients prefer long-term use with home refills.

© Copyright 2025. All Rights Reserved by MedPath